Benzinga · Apr 6, 2026
IB
AMEX · IBO
Impact BioMedical Inc.
Healthcare · Biotechnology
$0.50
Up+$0.07 (+14.56%)
Updated Sep 17, 2026, 5:29 PM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 6.1M
- P/E ratio
- -0.15
- Dividend yield
- 0.00%
- 52-week range
- $0.37 – $0.83
- Volume
- 164.69K
- Avg. volume
- 143.99K
Price performance
IBO price history
1M range · 20 trading sessions · Daily adjusted prices
IBO closed at $0.50 after 20 trading sessions, up 14.96% for the selected period.
- Last close
- $0.50
- Period change
- +14.96%
- Period low
- $0.43
- Period high
- $0.54
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $0.54 | $0.547 | $0.498 | $0.498 | 164.69K |
| Sep 15, 2026 | $0.48 | $0.5489 | $0.4785 | $0.529 | 121.75K |
| Sep 14, 2026 | $0.4521 | $0.5179 | $0.4521 | $0.4841 | 113.01K |
| Sep 11, 2026 | $0.4467 | $0.49 | $0.4467 | $0.4602 | 310.59K |
| Sep 10, 2026 | $0.475 | $0.5082 | $0.4337 | $0.441 | 272.46K |
| Sep 9, 2026 | $0.509 | $0.51 | $0.4818 | $0.4937 | 49.15K |
| Sep 8, 2026 | $0.51 | $0.5337 | $0.50 | $0.50 | 151.05K |
| Sep 4, 2026 | $0.48 | $0.64 | $0.47 | $0.54 | 4.13M |
| Sep 3, 2026 | $0.48 | $0.489 | $0.4701 | $0.48 | 82.43K |
| Sep 2, 2026 | $0.4724 | $0.49 | $0.46 | $0.49 | 45.12K |
| Sep 1, 2026 | $0.483 | $0.49 | $0.4556 | $0.458 | 26.68K |
| Aug 31, 2026 | $0.441 | $0.4705 | $0.441 | $0.4611 | 8.41K |
| Aug 28, 2026 | $0.4437 | $0.46 | $0.442 | $0.4437 | 6.73K |
| Aug 27, 2026 | $0.44 | $0.4605 | $0.44 | $0.441 | 51.33K |
| Aug 26, 2026 | $0.447 | $0.4877 | $0.44 | $0.4401 | 13.09K |
| Aug 25, 2026 | $0.474 | $0.489 | $0.44 | $0.4602 | 53.83K |
| Aug 24, 2026 | $0.4544 | $0.4776 | $0.4511 | $0.453 | 14.21K |
| Aug 21, 2026 | $0.4383 | $0.48 | $0.4383 | $0.48 | 22.75K |
| Aug 20, 2026 | $0.4302 | $0.4588 | $0.4302 | $0.4493 | 24.41K |
| Aug 19, 2026 | $0.4558 | $0.4629 | $0.4332 | $0.4332 | 31.4K |
Latest IBO news
The latest Smart Investors Daily articles mentioning IBO.
Stock researchCompany · Overview
IBO research
Overview
Company profile and research snapshot.
Company profile
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Benzinga · Mar 27, 2026
12 Health Care Stocks Moving In Friday's Pre-Market Session
ChartMill · Mar 23, 2026
Wondering what's happening in today's pre-market session?
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Benzinga · Mar 23, 2026
12 Health Care Stocks Moving In Monday's Pre-Market Session
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
